I don't think LP sucked on this financing. If thermo is right, she dug in and raised the price by 15% when the deal was already inked. It seems like she looked out for her shareholder base on this one. The 10-day average was agreed before the run-up hit and then the number looked bad so she renegotiated (but with limited leverage). I think the evidence that LP and company are internalizing the costs of dilution is an encouraging signal. It hasn't always seemed to be the case.
30% warrant coverage restricted 90 days (at 2 bucks!) doesn't distress me at all. If the prospectus is correct (and it had better be :-), the entire raise goes to the company--no fee overhang here, so it seems like a smart play. I'm a long-term owner of NWBO and am bullish on its future, so take my bias with a grain of salt.
News 
Market Data 
Discover 
AI
